Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch by Michallet, M, Dreger, P, Sutton, L, Brand, R, Richards, S, van Biezen, A, Sobh, M, Gratwohl, A, Kolbe, K, Dearden, C, Hallek, M, de Witte, T, Niederwieser, D, Leporrier, M, Milligan, D

Autologous haematopoietic stem cell transplantation in CLL: first results of an EBMT randomized trial comparing autotransplant versus wait and watch by Michallet, M, Dreger, P, Sutton, L, Brand, R, Richards, S, Van Biezen, A, Sobh, M, Gratwohl, A, Kolbe, K, Dearden, C, Hallek, M, De Witte, T, Niederwieser, D, Leporrier, M, Milligan, D

Final results of a randomized trial comparing autotransplant versus wait and watch in 222 patients with CLL in 1(st) or 2(nd) remission (EBMT CLL auto trial / GCLLSG CLL3R trial) by McClanahan, F, Michallet, M, Milligan, D, Sutton, L, Brand, R, Richards, S, Van Biezen, A, Sobh, M, Gratwohl, A, Herr, W, Dearden, C, Hallek, M, Stilgenbauer, S, De Witte, T, Niederwieser, D, Leporrier, M, Dreger, P

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation. by Michallet, M, Dreger, P, Sutton, L, Brand, R, Richards, S, van Os, M, Sobh, M, Choquet, S, Corront, B, Dearden, C, Gratwohl, A, Herr, W, Catovsky, D, Hallek, M, de Witte, T, Niederwieser, D, Leporrier, M, Milligan, D

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes by Garcia-Manero, G, Santini, V, Almeida, A, Platzbecker, U, Jonasova, A, Silverman, LR, Falantes, J, Reda, G, Buccisano, F, Fenaux, P, Buckstein, R, Diez Campelo, M, Larsen, S, Valcarcel, D, Vyas, P, Giai, V, Olíva, EN, Shortt, J, Niederwieser, D, Mittelman, M, Fianchi, L, La Torre, I, Zhong, J, Laille, E, Lopes de Menezes, D, Skikne, B, Beach, CL, Giagounidis, A